Your browser doesn't support javascript.
loading
Glioma progression is shaped by genetic evolution and microenvironment interactions.
Varn, Frederick S; Johnson, Kevin C; Martinek, Jan; Huse, Jason T; Nasrallah, MacLean P; Wesseling, Pieter; Cooper, Lee A D; Malta, Tathiane M; Wade, Taylor E; Sabedot, Thais S; Brat, Daniel; Gould, Peter V; Wöehrer, Adelheid; Aldape, Kenneth; Ismail, Azzam; Sivajothi, Santhosh K; Barthel, Floris P; Kim, Hoon; Kocakavuk, Emre; Ahmed, Nazia; White, Kieron; Datta, Indrani; Moon, Hyo-Eun; Pollock, Steven; Goldfarb, Christine; Lee, Ga-Hyun; Garofano, Luciano; Anderson, Kevin J; Nehar-Belaid, Djamel; Barnholtz-Sloan, Jill S; Bakas, Spyridon; Byrne, Annette T; D'Angelo, Fulvio; Gan, Hui K; Khasraw, Mustafa; Migliozzi, Simona; Ormond, D Ryan; Paek, Sun Ha; Van Meir, Erwin G; Walenkamp, Annemiek M E; Watts, Colin; Weiss, Tobias; Weller, Michael; Palucka, Karolina; Stead, Lucy F; Poisson, Laila M; Noushmehr, Houtan; Iavarone, Antonio; Verhaak, Roel G W.
Afiliación
  • Varn FS; The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
  • Johnson KC; The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
  • Martinek J; The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
  • Huse JT; Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Nasrallah MP; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Wesseling P; Amsterdam University Medical Centers/VUmc, Amsterdam, the Netherlands; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Cooper LAD; Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
  • Malta TM; School of Pharmaceutical Sciences of Ribeirao Preto, University of São Paulo, Brazil, Ribeirao Preto, São Paulo, Brazil.
  • Wade TE; The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
  • Sabedot TS; Hermelin Brain Tumor Center, Henry Ford Health System, Detroit, MI, USA.
  • Brat D; Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
  • Gould PV; service d'anatomopathologie, Hôpital de l'Enfant-Jésus du Centre hospitalier universitaire de Québec, Université Laval, Quebec City, QC, Canada.
  • Wöehrer A; Division of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, Vienna, Austria.
  • Aldape K; National Cancer Institute, Bethesda, MD, USA.
  • Ismail A; Department of Cellular and Molecular Pathology, Leeds Teaching Hospital NHS Trust, St James's University Hospital, Leeds, UK.
  • Sivajothi SK; The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
  • Barthel FP; The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA; Cancer and Cell Biology Division, the Translational Genomics Research Institute, Phoenix, AZ, USA.
  • Kim H; The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA; Department of Biopharmaceutical Convergence, Department of Pharmacy, Sungkyunkwan University, Suwon-si, Gyeong gi-do, South Korea.
  • Kocakavuk E; The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA; Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, Essen, Germany.
  • Ahmed N; University of Leeds, Leeds, UK.
  • White K; Precision Cancer Medicine Group, Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, D02 YN77 Dublin, Ireland.
  • Datta I; Department of Public Health Sciences, Hermelin Brain Tumor Center, Henry Ford Health System, Detroit, MI, USA.
  • Moon HE; Seoul National University College of Medicine and Seoul National University Hospital, Seoul, Republic of Korea.
  • Pollock S; University of Leeds, Leeds, UK.
  • Goldfarb C; The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
  • Lee GH; The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
  • Garofano L; Institute for Cancer Genetics, Columbia University Medical Center, New York, NY, USA.
  • Anderson KJ; The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
  • Nehar-Belaid D; The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
  • Barnholtz-Sloan JS; Case Western Reserve University School of Medicine and University Hospitals of Cleveland, Cleveland, OH, USA; Center for Biomedical Informatics and Information Technology & Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
  • Bakas S; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA; Department of Radiology, University of Pennsylvania, Philadelphia, PA, USA.
  • Byrne AT; Precision Cancer Medicine Group, Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, D02 YN77 Dublin, Ireland.
  • D'Angelo F; Institute for Cancer Genetics, Columbia University Medical Center, New York, NY, USA.
  • Gan HK; Olivia Newton-John Cancer Research Institute, Austin Health, Melbourne, Australia.
  • Khasraw M; Preston Robert Tisch Brain Tumor Center at Duke, Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA.
  • Migliozzi S; Institute for Cancer Genetics, Columbia University Medical Center, New York, NY, USA.
  • Ormond DR; Department of Neurosurgery, University of Colorado School of Medicine, Aurora, CO, USA.
  • Paek SH; Seoul National University College of Medicine and Seoul National University Hospital, Seoul, Republic of Korea.
  • Van Meir EG; Department of Neurosurgery, School of Medicine and O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Walenkamp AME; Department of Medical Oncology, University Medical Center Groningen, Groningen, the Netherlands.
  • Watts C; Academic Department of Neurosurgery, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
  • Weiss T; Department of Neurology, Clinical Neuroscience Center, University Hospital Zurich and University of Zürich, Switzerland.
  • Weller M; Department of Neurology, Clinical Neuroscience Center, University Hospital Zurich and University of Zürich, Switzerland.
  • Palucka K; The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
  • Stead LF; University of Leeds, Leeds, UK.
  • Poisson LM; Department of Public Health Sciences, Hermelin Brain Tumor Center, Henry Ford Health System, Detroit, MI, USA.
  • Noushmehr H; Hermelin Brain Tumor Center, Henry Ford Health System, Detroit, MI, USA.
  • Iavarone A; Institute for Cancer Genetics, Columbia University Medical Center, New York, NY, USA; Department of Neurology, Columbia University Medical Center, New York, NY, USA; Department of Pathology and Cell Biology, Columbia University Medical Center, New York, NY, USA; Herbert Irving Comprehensive Cancer C
  • Verhaak RGW; The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA; Department of Neurosurgery, Amsterdam University Medical Centers/VUmc, Amsterdam, the Netherlands. Electronic address: roel.verhaak@jax.org.
Cell ; 185(12): 2184-2199.e16, 2022 06 09.
Article en En | MEDLINE | ID: mdl-35649412
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Microambiente Tumoral / Glioma Tipo de estudio: Prognostic_studies Límite: Adult / Humans Idioma: En Revista: Cell Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Microambiente Tumoral / Glioma Tipo de estudio: Prognostic_studies Límite: Adult / Humans Idioma: En Revista: Cell Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos